A Low Beta Way to Play Biopharma Industry

Attached is a piece about SWKH in which I discuss the value within the company, and I suggest it as a way of exposure to the healthcare technology sector without the risk. How is that possible? SWKH uses debt investments when making acquisitions in companies. Debt investments are usually the first investments to be paid back in full when a company undergoes liquidation / bankruptcy. Give it a read and let me know what y'all think.

rockvuecapital.wordpress.com/2017/05/22/another-way-to-play-pharmaceuticals-swkh/

All the best,
RC